Analysis

Southwest Airlines (LUV): Factors that clouded the airline’s Q1 performance

Shares of Southwest Airlines Co. (NYSE: LUV) plummeted on Thursday after the company missed expectations on its first quarter 2024 earnings results.

Domino’s Pizza to report Q1 earnings next week. Here’s what to expect

Fast food giant Domino's Pizza, Inc. (NYSE: DPZ) is preparing to release operating results for the first three months of fiscal 2024.

Main takeaways from Hasbro’s (HAS) Q1 2024 earnings report

Shares of Hasbro, Inc. (NASDAQ: HAS) soared 11% on Wednesday after the company delivered better-than-expected earnings results for the first quarter of

Interviews

AlphaStreet's dedicated Earnings Call section is your one-source destination for all publicly listed earnings conference calls. Listen to CEOs/CFOs discuss their company's earnings reports while Wall Street Analysts ask (or grill) with their hard hitting questions.

Most Read

CL Earnings: Key quarterly highlights from Colgate-Palmolive’s Q1 2024 financial results

Colgate-Palmolive Company (NYSE: CL) reported first quarter 2024 earnings results today. Net sales increased 6.2% year-over-year to $5.06 billion. Organic sales increased 9.8%. Net income attributable to Colgate-Palmolive Company was

April 26, 2024

Microsoft (MSFT) reports higher revenue and profit for Q3 2024

Microsoft Corp. (NASDAQ: MSFT) on Thursday said its third-quarter 2024 earnings increased year-over-year, reflecting strong performance by the tech giant’s main operating segments. Third-quarter revenues came in at $61.86 billion,

April 25, 2024

GOOG, GOOGL Earnings: All you need to know about Alphabet’s Q1 2024 earnings results

Alphabet Inc. (NASDAQ: GOOG, GOOGL) reported its first quarter 2024 earnings results today. Revenues increased 15% year-over-year to $80.5 billion. Revenue growth was 16% in constant currency. Net income was

April 25, 2024

Research Summary

Ocean Biomedical, Inc. (NASDAQ: OCEA) Research Summary

Ocean Biomedical, Inc. (NASDAQ: OCEA) is a biotechnology company that works with leading researchers

Trxade Health Inc. (NASDAQ: MEDS) Q4 2023 Research Summary

Trxade Health, Inc. (NASDAQ: MEDS) operates as an integrated drug procurement and delivery platform,

Viewing Highlight
Loading...
Highlight
Close
Top